WARNER BROS. DISCOVERY, INC. (WBD)
Warner Bros. Discovery Announces Receipt of Requisite Consents for Proposed Amendments in Consent Solicitations
Warner Bros. Discovery Announces Receipt of Requisite Consents for Proposed Amendments in Consent Solicitations
Insmed to Present at the 2026 Goldman Sachs Annual Global Healthcare Conference
Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapogene imadenovec-drba) in the United States
RADCOM to Participate in William Blairs 46th Annual Growth Stock Conference
Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology
Autolus Therapeutics to Participate in Upcoming Investor Conferences
Sound Point Meridian Capital, Inc. Announces Results for the Fourth Fiscal Quarter Ended March 31, 2026
Viridian Therapeutics to Participate in Upcoming June Investor Conferences
Harrow to Present at William Blair’s 46th Annual Growth Stock Conference
LeonaBio to Participate in Upcoming Medical and Industry Meetings in June